Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4.

Cavallari J F, Fullerton M D, Duggan B M, Foley K P, Denou E, Smith B K, Desjardins E M, Henriksbo B D, Kim K J, Tuinema B R, Stearns J C, Prescott D, Rosenstiel P, Coombes B K, Steinberg G R, Schertzer J D (2017); Cell Metab., 25(5):1063-1074. doi: 10.1016/j.cmet.2017.03.021